Verapamil盐酸维拉帕米,152-11-4

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Verapamil hydrochloride

CAS No. : 152-11-4

MCE 国际站：Verapamil hydrochloride

产品活性：Verapamil hydrochloride ((±)-Verapamil hydrochloride) 是一种钙通道 (calcium channel) 阻滞剂，是一种有效的口服活性的第一代 P 糖蛋白 (P-gp) 抑制剂。Verapamil hydrochloride 能也抑制 CYP3A4，并可用于高血压，心律不齐和心绞痛的研究。

研究领域：Membrane Transporter/Ion Channel  |  Neuronal Signaling  |  Metabolic Enzyme/Protease

作用靶点：Calcium Channel  |  P-glycoprotein  |  Cytochrome P450

In Vitro: The EverFluor FL Verapamil (EFV) uptake by TR-iBRB2 cells is inhibited by cationic drugs, and inhibits by verapamil in a concentration-dependent manner with an IC₅₀ of 98.0 μM.

In Vivo: Given orally Verapamil is useful for the prophylaxis of atrioventricular reentry tachycardia, and also in modulating the atrioventricular nodal response in atrial fibrillation.
Verapamil is injected i.v. into a femoral vein prior to ischemia. Verapamil (1 mg/kg) significantly decreases the incidence of ventricular arrhythmias including premature ventricular contractions (PVC), ventricular tachycardia (VT) and ventricular fibrillation (VF) for 45-min coronary artery occlusion. Total arrhythmia scores are significantly increased when the heart is subjected to ischemia. Verapamil (1 mg/kg) significantly prevents the enhancement of total arrhythmia scores induced by ischemia.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Membrane Transporter/Ion Channel Compound Library  |  Metabolism/Protease Compound Library  |  Neuronal Signaling Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Antiviral Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Antioxidant Compound Library  |  Oxygen Sensing Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  NMPA-Approved Drug Library  |  Orally Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Neuroprotective Compound Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Mitochondria-Targeted Compound Library  |  Rare Diseases Drug Library  |  Children’s Drug Library  |  Calcium Channel Blocker Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Cancer Stem Cells Compound Library  |  Off-patent Drug Library  |  Antihypertensive Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Ion Channel Compound Library  |  Thapsigargin  |  Ionomycin  |  L-Ascorbic acid  |  Minocycline hydrochloride  |  Verapamil  |  2-Aminoethyl diphenylborinate  |  Apigenin  |  Fenofibrate  |  Acetylcholine chloride  |  GSK1016790A  |  Chlorpromazine hydrochloride  |  Ketoconazole  |  Nifedipine  |  Fasudil Hydrochloride  |  1-Aminobenzotriazole  |  Elacridar  |  Letrozole  |  Abiraterone  |  Ebselen  |  Itraconazole  |  Halofuginone  |  Cepharanthine  |  Glibenclamide  |  Tariquidar  |  Quinidine (15% dihydroquinidine)  |  Tetrandrine  |  Carbamazepine  |  Zosuquidar trihydrochloride

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds